Considering METTL16 is also a putative m6A methyltransferase and knockdown of METTL16 could result in approximately 20% decrease of m6A [29], we also investigated the expression of METTL16 in gliomas with different malignancy status in the CGGA dataset (Figure S1). The gene discussed is METTL16; the disease is central nervous system cancer.